hydralazine and olmesartan medoxomil

hydralazine has been researched along with olmesartan medoxomil in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (60.00)	29.6817
2010's	4 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Higaki, J; Kamide, K; Moriguchi, K; Nagai, M; Ogihara, T; Ohishi, M; Okamura, A; Rakugi, H; Satoh, N; Tuck, ML	1
Inagi, R; Ishikawa, N; Koike, H; Kurokawa, K; Miyata, T; Mizuno, M; Nangaku, M; Sada, T; Ueda, Y; van Ypersele de Strihou, C; Yuzawa, H	1
Ishikawa, N; Kurokawa, K; Miyata, T	1
Abe, Y; Fan, Y; Kimura, S; Kobori, H; Nishiyama, A; Rahman, M; Seth, DM; Shokoji, T; Yao, L; Zhang, GX	1
Abe, Y; Kimura, S; Kiyomoto, H; Kobori, H; Kohno, M; Miyata, K; Miyatake, A; Nagai, Y; Nishiyama, A; Ozawa, Y; Shokoji, T; Yao, L; Yukimura, T	1
Ferrario, CM; Gallagher, PE; Geary, RL; Igase, M; Strawn, WB	1
Cervenka, L; Fukuoka, N; Hitomi, H; Houchi, H; Kobara, H; Kobori, H; Kosaka, S; Masaki, T; Matsumura, Y; Mori, H; Nakano, D; Nishiyama, A; Pelisch, N; Rahman, M	1
Fujigaki, Y; Ishigaki, S; Isobe, S; Kato, A; Miyajima, H; Nishiyama, A; Ohashi, N; Sakao, Y; Tsuji, T; Yasuda, H	1

Reviews

2 review(s) available for hydralazine and olmesartan medoxomil

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 5 Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus; Diabetic Nephropathies; Glycation End Products, Advanced; Guanidines; Humans; Hydralazine; Hydrazines; Imidazoles; Olmesartan Medoxomil; Oxidative Stress; Pyridoxamine; Tetrazoles	2004

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

[Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy].

Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 5

Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus; Diabetic Nephropathies; Glycation End Products, Advanced; Guanidines; Humans; Hydralazine; Hydrazines; Imidazoles; Olmesartan Medoxomil; Oxidative Stress; Pyridoxamine; Tetrazoles

2004

Other Studies

8 other study(ies) available for hydralazine and olmesartan medoxomil

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. American journal of hypertension, 2002, Volume: 15, Issue:1 Pt 1 Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Catecholamines; Diet; Fructose; Glucose Tolerance Test; Heart Rate; Hydralazine; Hyperinsulinism; Hypertrophy, Left Ventricular; Imidazoles; Insulin; Male; Myocardium; Olmesartan Medoxomil; Organ Size; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles	2002
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:5 Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles	2003
Olmesartan improves endothelin-induced hypertension and oxidative stress in rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:7 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Endothelin-1; Hydralazine; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Superoxides; Tetrazoles; Thiobarbituric Acid Reactive Substances	2004
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Hydralazine; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; NADPH Oxidases; Olmesartan Medoxomil; Prediabetic State; Rats; Rats, Inbred OLETF; Receptors, Angiotensin; Renin; Tetrazoles; Thiazepines; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta	2005
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Atenolol; Carboxypeptidases; Carotid Arteries; Gene Expression Regulation, Enzymologic; Hydralazine; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Vasodilator Agents	2005
Effects of angiotensin II AT₁-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats. Journal of pharmacological sciences, 2013, Volume: 121, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Diet, High-Fat; Endothelium, Vascular; Hydralazine; Hypertension; Imidazoles; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Olmesartan Medoxomil; Oxidative Stress; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Superoxides; Tetrazoles; Thiobarbituric Acid Reactive Substances; Vasodilation	2013
Augmented circadian rhythm of the intrarenal renin-angiotensin systems in anti-thymocyte serum nephritis rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2016, Volume: 39, Issue:5 Topics: Angiotensin II; Angiotensinogen; Animals; Antilymphocyte Serum; Circadian Rhythm; Disease Models, Animal; Hydralazine; Kidney; Lymphocytes; Male; Nephritis; Olmesartan Medoxomil; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System	2016